<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319711408284</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319711408284</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Coronary Heart Disease</subject>
</subj-group>
</article-categories>
<title-group><article-title>Differential Characteristics of Inflammatory Responses to Stent Implantation Between De Novo and Intrastent Restenosis Lesion in Patients With Stable Angina</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hikita</surname>
<given-names>Hiroyuki</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711408284">1</xref>
<xref ref-type="corresp" rid="corresp1-0003319711408284"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuroda</surname>
<given-names>Shunsuke</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711408284">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kawaguchi</surname>
<given-names>Naohiko</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711408284">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nakashima</surname>
<given-names>Emiko</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711408284">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fujinami</surname>
<given-names>Tatsuya</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711408284">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sugiyama</surname>
<given-names>Tomoyo</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711408284">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kamiishi</surname>
<given-names>Tetsuo</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711408284">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takahashi</surname>
<given-names>Yoshihide</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711408284">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nozato</surname>
<given-names>Toshihiro</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711408284">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuwahara</surname>
<given-names>Taishi</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711408284">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Satoh</surname>
<given-names>Akira</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319711408284">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takahashi</surname>
<given-names>Atsushi</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711408284">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Isobe</surname>
<given-names>Mitsuaki</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0003319711408284">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0003319711408284"><label>1</label>Yokosuka Kyosai Hospital, Yokosuka, Kanagawa, Japan</aff>
<aff id="aff2-0003319711408284"><label>2</label>University of Tsukuba, Tsukuba, Ibaragi, Japan</aff>
<aff id="aff3-0003319711408284"><label>3</label>Tokyo Medical and Dental University, Tokyo, Japan</aff>
<author-notes>
<corresp id="corresp1-0003319711408284">Hiroyuki Hikita, Cardiovascular Center, Yokosuka Kyosai Hospital, 1-16 Yonegahama-dori, Yokosuka, Kanagawa, Japan 238-8558. Email: <email>hhikita-circ@umin.ac.jp</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>63</volume>
<issue>2</issue>
<fpage>92</fpage>
<lpage>95</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Mechanical plaque rupture of coronary atherosclerotic plaque during stent implantation can increase serum levels of high-sensitivity C-reactive protein (hsCRP). Patients with stable angina pectoris were divided into 2 groups: one group included 186 patients with de novo lesion who underwent stent implantation (de novo group); the other group included 40 patients with intrastent restenosis (ISR) undergoing stent implantation (ISR group). The de novo group had a significant increase in hsCRP levels post stenting, while the ISR group showed no increase in hsCRP post stenting. Intravascular ultrasound with radiofrequency data analysis showed that the de novo group had larger percentage of both necrotic core area and fibrofatty area at the target lesion than the ISR group, while the ISR group had a larger percentage of fibrous area. Differential inflammatory response to stent implantation between the de novo plaque and in ISR lesion is related to lesion morphology.</p>
</abstract>
<kwd-group>
<kwd>coronary stent</kwd>
<kwd>C-reactive protein</kwd>
<kwd>intravascular ultrasound</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Coronary stent implantation, which dilates the stenotic lesion and reduces restenosis, is accompanied by medial damage or penetration into a necrotic core and increased arterial inflammation.<sup><xref ref-type="bibr" rid="bibr1-0003319711408284">1</xref></sup> High-sensitivity C-reactive protein (hsCRP) is a biomarker for low-grade inflammation and has been implicated in several aspects of coronary atherogenesis and plaque vulnerability.<sup><xref ref-type="bibr" rid="bibr2-0003319711408284">2</xref><xref ref-type="bibr" rid="bibr3-0003319711408284"/><xref ref-type="bibr" rid="bibr4-0003319711408284"/><xref ref-type="bibr" rid="bibr5-0003319711408284"/><xref ref-type="bibr" rid="bibr6-0003319711408284"/>–<xref ref-type="bibr" rid="bibr7-0003319711408284">7</xref></sup> Medial injury and necrotic core penetration by stenting has been reported to elevate hsCRP after stent implantation, the so-called mechanical plaque rupture, in a small number of participants.<sup><xref ref-type="bibr" rid="bibr2-0003319711408284">2</xref>,<xref ref-type="bibr" rid="bibr5-0003319711408284">5</xref></sup> Coronary plaque which is penetrated by stenting varies from lipid-rich to fibrous-rich. We investigated the differential inflammatory response to stenting based on target lesion morphology in patients with stable angina pectoris.</p>
<sec id="section1-0003319711408284">
<title>Methods</title>
<sec id="section2-0003319711408284">
<title>Participants</title>
<p>We included 226 patients with stable angina pectoris with Canadian Cardiac Society class 2 or 3 who received dual antiplatelet therapy and underwent elective percutaneous coronary intervention (PCI) with single stenting following preintervention intravascular ultrasound (IVUS). Patients with active inflammatory diseases, chronic total occlusion, and severe angulations or calcification under which it was difficult to cross an intravascular ultrasound catheter were excluded. Stable angina was defined as no change in frequency, duration, or intensity of symptoms within 4 weeks. All patients received dual antiplatelet agents (aspirin 100 mg/d and either ticlopidine 200 mg/d or clopidogrel 75 mg/d) from at least 4 days before stent implantation.</p>
</sec>
<sec id="section3-0003319711408284">
<title>Preintervention IVUS and PCI</title>
<p>Percutaneous coronary intervention was performed from either the femoral or the radial artery. Coronary angiography was performed prior to IVUS with either a 6F or 7F guiding catheter. After intracoronary administration of isosorbide dinitrate (1 mg), the intravascular ultrasound catheter (Eagle Eye, Volcano Therapeutics, Inc., Rancho Cordova, California) was positioned sufficiently distal (&gt;10 mm distal) to the stent implantation site with automatic pullback performed at 0.5 mm/s. Gray-scale IVUS images of the target lesion were observed. Spectral analysis of IVUS radiofrequency data acquisition (IVUS-Virtual Histology [IVUS-VH]; Volcano Therapeutics) was also performed. Details regarding validation of the technique on explanted human coronary segments have been reported.<sup><xref ref-type="bibr" rid="bibr8-0003319711408284">8</xref><xref ref-type="bibr" rid="bibr9-0003319711408284"/><xref ref-type="bibr" rid="bibr10-0003319711408284"/>–<xref ref-type="bibr" rid="bibr11-0003319711408284">11</xref></sup> External elastic membrane (EEM) and lumen borders were identified using automatic edge detection and manually corrected when necessary. For the de novo lesion, plaque area was defined as EEM cross-sectional area minus lumen area. For the in stent restenosis lesion, plaque area was defined as stent area minus lumen area. Subsequently, IVUS-VH automatically classified the plaque into 4 components: fibrous (labeled green), fibro-fatty (labeled yellow), necrotic core (labeled red), and dense calcium (labeled white). The ratio of each plaque component of culprit lesions was expressed as percentage of total plaque area. Cross-sectional analysis was performed at minimum lumen sites. Quantitative coronary angiogram analysis was performed before and after the completion of PCI. Percutaneous coronary intervention included stent implantation with a drug-eluting stent for either de novo lesions or intrastent restenosis (ISR) lesions. All patients provided written informed consent.</p>
</sec>
<sec id="section4-0003319711408284">
<title>Blood Sampling</title>
<p>Venous blood was drawn from all patients before PCI and 24 hours after the completion of PCI in a fasting state. Serum hsCRP levels were determined using a latex agglutination turbidimetric immunoassay with a coefficient of variation &lt;2% (Nanopia CRP, Sekisui Medical Co. Ltd., Tokyo, Japan). The lower detection limit was 0.01 mg/dL. Values of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein –cholesterol (HDL-C), triglyceride, and hemoglobin A1c (HbA1c) were measured before PCI.</p>
</sec>
<sec id="section5-0003319711408284">
<title>Statistical Analysis</title>
<p>Data are expressed as mean ± SD. Continuous variables were compared using the unpaired Student <italic>t</italic> test. Chi-square analysis was used to test the differences between proportions. Fisher exact test was used when the expected value for a cell was &lt;5. Simple correlations were examined using Pearson coefficient of correlation. All statistical analyses were performed using JMP version 6 (SAS Inc, Chicago, Illinois). Significance was defined as <italic>P</italic> &lt; .05.</p>
</sec>
</sec>
<sec id="section6-0003319711408284">
<title>Results</title>
<p>The study patients were divided into 2 groups according to lesion type: the ISR lesion group and de novo lesion group. Patient clinical characteristics and angiographic findings between the 2 groups are shown in <xref ref-type="table" rid="table1-0003319711408284">Tables 1</xref> and <xref ref-type="table" rid="table2-0003319711408284">2</xref>, respectively. There were no significant differences between the 2 groups in terms of clinical characteristics and angiographic findings.</p>
<table-wrap id="table1-0003319711408284" position="float">
<label>Table 1.</label>
<caption>
<p>Patients Clinical Characteristics in the 2 Groups<sup><xref ref-type="table-fn" rid="table-fn2-0003319711408284">a</xref></sup></p>
</caption>
<graphic alternate-form-of="table1-0003319711408284" xlink:href="10.1177_0003319711408284-table1.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>ISR Lesion</th>
<th>De Novo Lesion</th>
</tr>
</thead>
<tbody>
<tr>
<td>Number of patients</td>
<td align="center">40</td>
<td align="center">186</td>
</tr>
<tr>
<td>Men/women</td>
<td align="center">30/10</td>
<td align="center">131/55</td>
</tr>
<tr>
<td>Age (years)</td>
<td>65.5 ± 7.7</td>
<td>63.5 ± 11.5</td>
</tr>
<tr>
<td>BMI (kg/m<sup>2</sup>)</td>
<td>22.8 ± 5.9</td>
<td>23.4 ± 5.5</td>
</tr>
<tr>
<td>Hypertension</td>
<td>27 (68%)</td>
<td>142 (76%)</td>
</tr>
<tr>
<td>Dyslipidemia</td>
<td>23 (58%)</td>
<td>112 (60%)</td>
</tr>
<tr>
<td>Smoking</td>
<td>16 (40%)</td>
<td>83 (45%)</td>
</tr>
<tr>
<td>Diabetes mellitus</td>
<td>19 (48%)</td>
<td>94 (51%)</td>
</tr>
<tr>
<td>LDL-cholesterol (mg/dL)</td>
<td>119 ± 36</td>
<td>108 ± 38</td>
</tr>
<tr>
<td>HDL-cholesterol (mg/dl)</td>
<td>41 ± 10</td>
<td>43 ± 11</td>
</tr>
<tr>
<td>Triglyceride (mg/dL)</td>
<td>158 ± 37</td>
<td>155 ± 39</td>
</tr>
<tr>
<td>HbA1c (%)</td>
<td>6.1 ± 3.2</td>
<td>6.3 ± 3.3</td>
</tr>
<tr>
<td>Statin before PCI</td>
<td>31 (78%)</td>
<td>144 (77%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0003319711408284">
<p>Abbreviations: BMI, body mass index; ISR, intrastent restenosis; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PCI, percutaneous coronary intervention; SD, standard deviation.</p>
</fn>
<fn id="table-fn2-0003319711408284">
<p>
<sup>a</sup> Mean ± SD.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table2-0003319711408284" position="float">
<label>Table 2.</label>
<caption>
<p>Angiographic Findings in the 2 Groups<sup><xref ref-type="table-fn" rid="table-fn4-0003319711408284">a</xref></sup></p>
</caption>
<graphic alternate-form-of="table2-0003319711408284" xlink:href="10.1177_0003319711408284-table2.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>ISR Lesion</th>
<th>De Novo Lesion</th>
</tr>
</thead>
<tbody>
<tr>
<td>Target vessel (LAD/LCX/RCA)</td>
<td align="center">23/8/9</td>
<td align="center">107/37/42</td>
</tr>
<tr>
<td>Reference diameter (mm)</td>
<td>2.78 ± 0.63</td>
<td>2.73 ± 0.51</td>
</tr>
<tr>
<td>% DS after PCI (%)</td>
<td>5.6 ± 8.3</td>
<td>8.1 ± 6.4</td>
</tr>
<tr>
<td>MLD after PCI (mm)</td>
<td>2.61 ± 0.56</td>
<td>2.69 ± 0.54</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0003319711408284">
<p>Abbreviations: DS, diameter stenosis; ISR, intrastent restenosis; LAD, left descending artery; LCX, left circumflex artery; MLD, minimal lumen diameter; PCI, percutaneous coronary intervention; RCA, right coronary artery; SD, standard deviation.</p>
</fn>
<fn id="table-fn4-0003319711408284">
<p>
<sup>a</sup> Mean ± SD.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Serum hsCRP levels in the de novo lesion group were significantly increased from before PCI to 24 hours after the completion of PCI (2.0 ± 3.0 to 6.6 ± 5.5 mg/L, <italic>P</italic> &lt; .001), while CRP levels in the ISR group were not increased (3.2 ± 3.5 to 3.5 ± 2.3 mg/L).</p>
<p>The IVUS findings between the 2 groups are shown in <xref ref-type="table" rid="table3-0003319711408284">Table 3</xref>. The average percentage of necrotic core component and percentage of fibro-fatty component were higher in the de novo lesion group than in the ISR group, while the average percentage of fibrous component was higher in the ISR group than in the de novo lesion group.</p>
<table-wrap id="table3-0003319711408284" position="float">
<label>Table 3.</label>
<caption>
<p>Intravascular Ultrasound (IVUS) Findings at the Target Lesion<sup><xref ref-type="table-fn" rid="table-fn6-0003319711408284">a</xref></sup></p>
</caption>
<graphic alternate-form-of="table3-0003319711408284" xlink:href="10.1177_0003319711408284-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>ISR Lesion</th>
<th>De Novo Lesion</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>VH lesion plaque area (mm<sup>2</sup>)</td>
<td>9.3 ± 1.2</td>
<td>10.0 ± 3.8</td>
<td>ns</td>
</tr>
<tr>
<td>VH % Fibrous area (%)</td>
<td>75.2 ± 13.3</td>
<td>60.5 ± 15.4</td>
<td>
<italic>P</italic> &lt; .01</td>
</tr>
<tr>
<td>VH % Fibrofatty area (%)</td>
<td>11.2 ± 6.7</td>
<td>16.4 ± 11.3</td>
<td>
<italic>P</italic> &lt; .01</td>
</tr>
<tr>
<td>VH % Necrotic area (%)</td>
<td>8.2 ±5.6</td>
<td>19.7 ±10.4</td>
<td>
<italic>P</italic> &lt; .01</td>
</tr>
<tr>
<td>VH % Dense calcium (%)</td>
<td>5.5 ± 5.3</td>
<td>3.5 ± 4.2</td>
<td>ns</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0003319711408284">
<p>Abbreviations: VH: virtual histology; SD, standard deviation; ns, not significant.</p>
</fn>
<fn id="table-fn6-0003319711408284">
<p>
<sup>a</sup> mean ± SD.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section7-0003319711408284">
<title>Discussion</title>
<p>This study demonstrated that elective stent implantation in stable angina patients induces a marked increase in serum hsCRP in the large number of participants with a de novo lesion but not with an ISR lesion. Differential inflammatory response to stent implantation between de novo plaque and an ISR lesion is related to lesion morphology.</p>
<p>Stent implantation causes medial injury and penetration into a necrotic core and induces vascular inflammation.<sup><xref ref-type="bibr" rid="bibr1-0003319711408284">1</xref></sup> Plaque morphology varies in stable angina from stable to vulnerable plaque which contains a large necrotic core component.<sup><xref ref-type="bibr" rid="bibr10-0003319711408284">10</xref>,<xref ref-type="bibr" rid="bibr12-0003319711408284">12</xref></sup> Histopathology of ISR lesions showed neointima containing proteoglycan-rich smooth muscle cells with small inflammatory infiltrates.<sup><xref ref-type="bibr" rid="bibr13-0003319711408284">13</xref></sup> Therefore, the inflammatory response to stent implantation is different. C-reactive protein is secreted from liver and coronary plaques accompanied by stent implantation.<sup><xref ref-type="bibr" rid="bibr5-0003319711408284">5</xref>,<xref ref-type="bibr" rid="bibr14-0003319711408284">14</xref></sup> A plaque which contains a large necrotic core component has been pathologically reported to include a greater amount of CRP<sup><xref ref-type="bibr" rid="bibr3-0003319711408284">3</xref>,<xref ref-type="bibr" rid="bibr15-0003319711408284">15</xref></sup> The plaque CRP level has been reported to be correlated with a systemic CRP level.<sup><xref ref-type="bibr" rid="bibr16-0003319711408284">16</xref></sup> A study indicated that systemic and local CRP levels after coronary stent implantation were higher in unstable angina than in stable angina.<sup><xref ref-type="bibr" rid="bibr5-0003319711408284">5</xref></sup> The higher hsCRP elevation after coronary stent implantation means that the more vulnerable plaque was dilated. A large inflammatory response after coronary stent implantation has been reported to be associated with restenosis and worse prognosis.<sup><xref ref-type="bibr" rid="bibr5-0003319711408284">5</xref>,<xref ref-type="bibr" rid="bibr17-0003319711408284">17</xref>,<xref ref-type="bibr" rid="bibr18-0003319711408284">18</xref></sup> One vulnerable plaque indicates that other vulnerable plaque exists in other regions of the coronary arteries.<sup><xref ref-type="bibr" rid="bibr19-0003319711408284">19</xref></sup> We used the ISR lesion as a model of plaque containing a greater fibrous portion, which was dilated with stent implantation without CRP elevation. Therefore, anti-inflammation therapy and plaque stabilization therapy, such as statin therapy, may be needed for reducing PCI-related CRP elevation, to prevent restenosis and secondary cardiac events.</p>
<p>We used IVUS-VH to determine plaque components. IVUS-VH enables a more detailed analysis of plaque composition and morphology. In vivo and ex vivo studies correlated 4 histological plaque components with IVUS-VH data.<sup><xref ref-type="bibr" rid="bibr8-0003319711408284">8</xref><xref ref-type="bibr" rid="bibr9-0003319711408284"/><xref ref-type="bibr" rid="bibr10-0003319711408284"/>–<xref ref-type="bibr" rid="bibr11-0003319711408284">11</xref></sup></p>
<p>One study limitation was that our patients were selected based on the same lesion characteristics and stent implantation strategy, which meant 1 stenotic lesion treated with 1 stent implantation. Another limitation includes the timing of evaluation of hsCRP and potential effects of other causes of elevation of hsCRP. High-sensitivity CRP has been reported to be elevated until 48 hours after coronary stent implantation.<sup><xref ref-type="bibr" rid="bibr5-0003319711408284">5</xref></sup> We evaluated the level of hsCRP 24 hours after coronary stent because patients were discharged in the morning 2 days after coronary stent implantation. We could not obtain blood samples from all the patients after 48 hours, yet CRP levels after coronary stenting were significantly increased from before stent implantation and 24 hours after stent implantation. Therefore, data of CRP at 24 hours after stent were used for evaluation of inflammatory response after stenting. Although we excluded participants with inflammatory disorders and with complications during PCI, such as myocardial infarction and large hematomas, we were not able to exclude the effect of puncture and deploying sheaths in the artery on hsCRP levels. Specific inflammatory markers for coronary plaque may be needed to exclude a systemic inflammatory response.</p>
</sec>
<sec id="section8-0003319711408284">
<title>Conclusions</title>
<p>Mechanical rupture of a stable atherosclerotic plaque (de novo lesion) induced by elective stent implantation induces a marked increase in serum hsCRP. The stimuli responsible for the elevation of serum CRP level may arise from within the atherosclerotic lesions, reflecting the degree of necrotic core component or fibro fatty component. Differential inflammatory response to stent implantation is related to lesion morphology.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0003319711408284">
<p>The author(s) declared no potential conflicts of interests with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0003319711408284">
<p>The author(s) received no financial support for the research and/or authorship of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319711408284">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farb</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sangiorgi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>AJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Pathology of acute and chronic coronary stenting in humans</article-title>. <source>Circulation</source>. <year>1999</year>;<volume>99</volume>(<issue>1</issue>):<fpage>44</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr2-0003319711408284">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almagor</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Keren</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Banai</surname>
<given-names>S.</given-names>
</name>
</person-group> <article-title>Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease</article-title>. <source>Am Heart J</source>. <year>2003</year>;<volume>145</volume>(<issue>2</issue>):<fpage>248</fpage>–<lpage>253</lpage>.</citation>
</ref>
<ref id="bibr3-0003319711408284">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pucci</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brscic</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tessitore</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>C-reactive protein and coronary composition in patients with percutaneous revascularization</article-title>. <source>Eur J Clin Invest</source>. <year>2008</year>;<volume>38</volume>(<issue>5</issue>):<fpage>281</fpage>–<lpage>289</lpage>.</citation>
</ref>
<ref id="bibr4-0003319711408284">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yip</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Hang</surname>
<given-names>CL</given-names>
</name>
<etal/>
</person-group>. <article-title>Levels and values of inflammatory markers in patients with angina pectoris</article-title>. <source>Int Heart J</source>. <year>2005</year>;<volume>46</volume>(<issue>4</issue>):<fpage>571</fpage>–<lpage>581</lpage>.</citation>
</ref>
<ref id="bibr5-0003319711408284">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Uchida</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting</article-title>. <source>J Am Coll Cardiol</source>. <year>2005</year>;<volume>46</volume>(<issue>2</issue>):<fpage>239</fpage>–<lpage>245</lpage>.</citation>
</ref>
<ref id="bibr6-0003319711408284">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otake</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shite</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shinke</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome</article-title>. <source>Am J Cardiol</source>. <year>2008</year>;<volume>101</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr7-0003319711408284">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Athyros</surname>
<given-names>VG</given-names>
</name>
<name>
<surname>Kakafika</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Karagiannis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mikhailidis</surname>
<given-names>DP.</given-names>
</name>
</person-group> <article-title>Do we need to consider inflammatory markers when we treat atherosclerotic disease?</article-title>. <source>Atherosclerosis</source>. <year>2008</year>;<volume>200</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr8-0003319711408284">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nair</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kuban</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Tuzcu</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Schoenhagen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nissen</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Vince</surname>
<given-names>DG.</given-names>
</name>
</person-group> <article-title>Coronary plaque classification with intravascular ultrasound radiofrequency data analysis</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>106</volume>(<issue>17</issue>):<fpage>2200</fpage>–<lpage>2206</lpage>.</citation>
</ref>
<ref id="bibr9-0003319711408284">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nasu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tsuchikane</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Katoh</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology</article-title>. <source>J Am CollCardiol</source>. <year>2006</year>;<volume>47</volume>(<issue>12</issue>):<fpage>2405</fpage>–<lpage>2412</lpage>.</citation>
</ref>
<ref id="bibr10-0003319711408284">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>König</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Klauss</surname>
<given-names>V.</given-names>
</name>
</person-group> <article-title>Virtual histology</article-title>. <source>Heart</source>. <year>2007</year>;<volume>93</volume>(<issue>8</issue>):<fpage>977</fpage>–<lpage>982</lpage>.</citation>
</ref>
<ref id="bibr11-0003319711408284">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nair</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Margolis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kuban</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Vince</surname>
<given-names>DG.</given-names>
</name>
</person-group> <article-title>Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation</article-title>. <source>EuroIntervention</source>. <year>2007</year>;<volume>3</volume>(<issue>1</issue>):<fpage>113</fpage>–<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr12-0003319711408284">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kruk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Przyluski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kalinczuk</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Cumulative incidence of coronary lesions with vulnerable characteristics in patients with stable angina pectoris: an intravascular ultrasound and angiographic study</article-title>. <source>Int J Cardiol</source>. <year>2005</year>;<volume>102</volume>(<issue>2</issue>):<fpage>201</fpage>–<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr13-0003319711408284">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chieffo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Foglieni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Laura</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stent</article-title>. <source>Am J Cardiol</source>. <year>2009</year>;<volume>104</volume>(<issue>12</issue>):<fpage>1660</fpage>–<lpage>1667</lpage>.</citation>
</ref>
<ref id="bibr14-0003319711408284">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pepys</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Hirschfield</surname>
<given-names>GM.</given-names>
</name>
</person-group> <article-title>C-reactive protein: a critical update</article-title>. <source>J Clin Invest</source>. <year>2003</year>;<volume>111</volume>(<issue>12</issue>):<fpage>1805</fpage>–<lpage>1812</lpage>.</citation>
</ref>
<ref id="bibr15-0003319711408284">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norja</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nuutila</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Karhunen</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Goebeler</surname>
<given-names>S.</given-names>
</name>
</person-group> <article-title>C-reactive protein in vulnerable coronary plaques</article-title>. <source>J Clin Pathol</source>. <year>2007</year>;<volume>60</volume>(<issue>5</issue>):<fpage>545</fpage>–<lpage>548</lpage>.</citation>
</ref>
<ref id="bibr16-0003319711408284">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Swan</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy</article-title>. <source>Atherosclerosis</source>. <year>2007</year>;<volume>191</volume>(<issue>1</issue>):<fpage>175</fpage>–<lpage>181</lpage>.</citation>
</ref>
<ref id="bibr17-0003319711408284">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>SY</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting</article-title>. <source>Circ J</source>. <year>2005</year>;<volume>69</volume>(<issue>12</issue>):<fpage>1477</fpage>–<lpage>1483</lpage>.</citation>
</ref>
<ref id="bibr18-0003319711408284">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>SY</given-names>
</name>
<etal/>
</person-group>. <article-title>Relation of soft plaque and elevated preprocedural high-sensitivity C-reactive protein levels to incidence of in-stent restenosis after successful coronary artery stenting</article-title>. <source>Am J Cardiol</source>. <year>2006</year>;<volume>98</volume>(<issue>3</issue>):<fpage>341</fpage>–<lpage>345</lpage>.</citation>
</ref>
<ref id="bibr19-0003319711408284">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toutouzas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Drakopoulou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Markou</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Correlation of systemic inflammation with local inflammatory activity in non-culprit lesions: beneficial effect of statins</article-title>. <source>Int J Cardiol</source>. <year>2007</year>;<volume>119</volume>(<issue>3</issue>):<fpage>368</fpage>–<lpage>73</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>